We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEON icon
151
AEON Biopharma
AEON
$13.4M
$5.56M 0.15%
+7,673
New +$5.5M
KVSA
152
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$5.49M 0.15%
549,968
FATP
153
DELISTED
Fat Projects Acquisition Corp Class A Ordinary Share
FATP
$5.45M 0.15%
537,265
KIII
154
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
$5.38M 0.15%
535,542
BNAI
155
Brand Engagement Network
BNAI
$99.4M
$5.37M 0.15%
53,291
+5,750
+12% +$574K
GXII
156
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
$5.34M 0.15%
+533,953
New +$5.28M
MBSC
157
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
$5.31M 0.15%
+523,800
New +$5.28M
ONMD icon
158
OneMedNet
ONMD
$42.1M
$5.29M 0.15%
+507,000
New +$5.29M
ADAL
159
DELISTED
Anthemis Digital Acquisitions I Corp Class A Ordinary Shares
ADAL
$5.29M 0.15%
+515,511
New +$5.24M
BIOT
160
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$5.26M 0.14%
520,364
GOGN
161
DELISTED
GoGreen Investments Corporation
GOGN
$5.24M 0.14%
+505,247
New +$5.18M
TWCB
162
DELISTED
Bilander Acquisition Corp. Class A Common Stock
TWCB
$5.21M 0.14%
526,950
NGC
163
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$5.21M 0.14%
518,681
PHYT
164
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$5.19M 0.14%
502,669
+37,800
+8% +$387K
OPA
165
DELISTED
Magnum Opus Acquisition Limited
OPA
$5.13M 0.14%
508,929
MBAC
166
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
$5.11M 0.14%
509,504
KRNL
167
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
$5.08M 0.14%
+503,354
New +$5.04M
MTVC
168
DELISTED
Motive Capital Corp II
MTVC
$5.07M 0.14%
495,177
+307,900
+164% +$3.11M
LOCC.U
169
DELISTED
Live Oak Crestview Climate Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one warrant
LOCC.U
$5.05M 0.14%
513,602
ACAH
170
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$5.04M 0.14%
503,433
+150,563
+43% +$1.49M
SKYA
171
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$4.9M 0.13%
+486,699
New +$4.85M
HPLT
172
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
$4.89M 0.13%
482,890
+150,000
+45% +$1.49M
K
173
DELISTED
Kellanova
K
$4.86M 0.13%
+72,633
New +$4.93M
LGVC
174
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$4.82M 0.13%
+469,981
New +$4.78M
AFAR
175
DELISTED
Aura FAT Projects Acquisition Corp Class A Ordinary Shares
AFAR
$4.81M 0.13%
+467,000
New +$4.74M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.